soft-tissue-sarcoma

Documents about soft-tissue-sarcoma

• The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma#238129ClinicalTrials.gov
• Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma#915609ClinicalTrials.gov
• Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma#917360ClinicalTrials.gov
• Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance#837692ClinicalTrials.gov
• Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma#845171ClinicalTrials.gov
• Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma#866991ClinicalTrials.gov
• Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery#881428ClinicalTrials.gov
• Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery#879730ClinicalTrials.gov
• A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma#886104ClinicalTrials.gov
• Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma#383576ClinicalTrials.gov
• Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma#966888ClinicalTrials.gov
• Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma#979967ClinicalTrials.gov
• Pharmacometabolomic of Trabectedin in Soft Tissue Patients#839552ClinicalTrials.gov
• Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma#876315ClinicalTrials.gov
• Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)#993427ClinicalTrials.gov
• Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma#1008204ClinicalTrials.gov
• Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis#810167ClinicalTrials.gov
• Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial#201772ClinicalTrials.gov
• Pemetrexed in Patients With Soft Tissue Sarcoma#825578ClinicalTrials.gov
• Alimta Plus Gemcitabine for Advanced Sarcoma#1008094ClinicalTrials.gov
• A Study of Ta-NPs Plus Radiotherapy for Locally Recurrent Retroperitoneal Sarcoma#858342ClinicalTrials.gov
• Improved Management of Soft Tissue Sarcomas Patients With an Optimized and Innovative Sorting Technology for Circulating Tumor Cells#835837ClinicalTrials.gov
• A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall#851064ClinicalTrials.gov
• Hypofractionated Radiotherapy for Soft Tissue Sarcomas#918890ClinicalTrials.gov
• T2* MRI Analysis for Sarcoma#867549ClinicalTrials.gov
• Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery#893792ClinicalTrials.gov
• Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma#280642IRIS
• Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma#366595ClinicalTrials.gov
• Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma#405135ClinicalTrials.gov
• Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)#836132ClinicalTrials.gov
• Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma#849996ClinicalTrials.gov
• Saving Limbs After Cancer: Blood Vessel and Soft Tissue Reconstruction Following Sarcoma Surgery in the Legs#856768ClinicalTrials.gov
• The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma#875603ClinicalTrials.gov
• Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma#848875ClinicalTrials.gov
• Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma#807307ClinicalTrials.gov
• Hyperthermia and Proton Therapy in Unresectable Soft Tissue Sarcoma#837356ClinicalTrials.gov
• Efficacy and Safety of L19TNF in Previously Treated Patients with Advanced Stage or Metastatic Soft-tissue Sarcoma#879770ClinicalTrials.gov
• Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma#208428ClinicalTrials.gov
• Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas#803541ClinicalTrials.gov
• Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor#874120ClinicalTrials.gov
• Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study#883812ClinicalTrials.gov
• Targeting ATR in Soft-tissue Sarcomas#901295ClinicalTrials.gov
• Retroperitoneal soft tissue sarcoma: prognostic factors and therapeutic approaches#418055IRIS
• Genomic Risk in Retroperitoneal Sarcoma#859137ClinicalTrials.gov
• The Effects of Observer Presence and Type on Patients' Perception of Exercise in Patients With Soft Tissue Sarcoma#891722ClinicalTrials.gov
• Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma#896005ClinicalTrials.gov
• Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma#858432ClinicalTrials.gov
• A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma#841855ClinicalTrials.gov
• A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)#850135ClinicalTrials.gov
• Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma#909139ClinicalTrials.gov